Book meetings with Participating Companies
Searching for organisations involved with diagnostics.
6 results found.
Displaying results 1 to 6.
If you were registered and approved, you would be able to see the
full profiles and book meetings with these companies.
High Force Research Ltd
High Force Research Ltd (HFR) offers confidential, high quality services for outsourced synthesis and R&D from the scale of grams to kilos for pharmaceuticals, life sciences and fine chemicals. Our team of chemists has wide experience of multi-step...
Innovaro Pharmalicensing
Innovaro Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Innovation Team
Innovation Team is the right product development partner for companies in medical technology. Start-ups and large companies in the Medicon Valley and UK contract our turn-key service to support product development from idea to production.Developing medtech...
NextGen Sciences
NextGen Sciences has been providing protein analytical services for ten years and we utilise that fundamental expertise to provide a superior and comprehensive biomarker and bioassay development service.
Keywords: assay development,
biomarkers,
companion diagnostics,
diagnostics,
enabling technologies,
in vitro,
molecular diagnostics,
peptides,
phase 1,
preclinical,
therapeutics
Theradex (Europe) Ltd
Theradex® is an international contract research organization providing complete professional services for the clinical research and development of pharmaceutical compounds, medical devices and diagnostic tests in the areas of oncology and life-threatening diseases.
Keywords: biomarkers,
biologics,
big pharma,
business advice,
companion diagnostics,
contracts,
diagnostics,
enabling technologies,
international,
partnering,
phase 1,
therapeutics,
vaccines
University of Copenhagen
We aim to license our technologies to the best possible partners for further development and commercialisation.Tech opportunities most relevant to this meeting: Early-stage CRC diagnostic plus disclosing antibodies microRNA cancer biomarkers Enhanced therapeutic DNA vaccines